Search Medical Condition
Please enter condition
Please choose location from dropdown

Nyanza Province, Kenya Clinical Trials

A listing of Nyanza Province, Kenya clinical trials actively recruiting patients volunteers.

RESULTS

Found (25) clinical trials

Sustainable East Africa Research in Community Health

The SEARCH study aims to test evidenced-based innovative community based interventions that lead to the elimination of HIV in rural communities in East Africa using a multi-disease approach. The first phase of the study will quantify the health, economic and educational impact of early HIV diagnosis using a streamlined and ...

Phase N/A

0.0 miles

Learn More »

A Surveillance Study of Diseases Specified as Adverse Events of Special Interest of Other Adverse Events Leading to Hospitalisation or Death and of Meningitis in Children in Africa Prior to Implementation of the RTS S/AS01E Candidate

The outcomes of interest (AESI, other AE leading to hospitalization or death, and meningitis) as well as data on malaria morbidity and mortality will be captured through active and enhanced hospitalization surveillance in children < 5 years of age. Children enrolled in active surveillance will be visited at their home ...

Phase N/A

0.35 miles

Learn More »

An Epidemiology Study of Malaria Transmission Intensity in Children in Sub-Saharan Africa

Nine annual cross sectional surveys at peak transmission will provide point estimates of parasite prevalence and subsequently a longitudinal assessment of the level of endemicity in each area covered by EPI-MAL-002 and EPI-MAL-003. This study will be conducted in parallel to EPI-MAL-002 and EPI-MAL-003 in order to assess parasite prevalence ...

Phase N/A

0.35 miles

Learn More »

Malaria Transmission and Immunity in Highland Kenya

The purpose of this study is to see why malaria epidemics occur in highland areas in Kenya. A better understanding of factors contributing to malaria may be necessary for malaria vaccine planning. These factors include interactions between age, where malaria is passed from mosquitoes to people, immune system (how the ...

Phase N/A

0.35 miles

Learn More »

A Combination HIV Prevention Strategy for Young Women at Risk for HIV

Despite remarkable advances in the global HIV response with 17 million persons, out of nearly 37 million living with HIV, who have initiated antiretroviral therapy (ART) in low- and middle-income countries (LMIC) as of end of 2015, there were an estimated 5,700 new HIV infections each day and a total ...

Phase N/A

0.35 miles

Learn More »

Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS

This study is being done to compare the safety and efficacy of three combination treatments for Kaposi's Sarcoma and AIDS.

Phase

0.35 miles

Learn More »

Safe Water Techniques in Kenya

Visit 400 households and distribute 1 of 3 different POU technologies on randomized basis for a two-month trial. Cycle each household through trials with all 3 technologies in random order such that at the end of 6 months all households have experienced 2-month trials with each technology.

Phase

0.35 miles

Learn More »

Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women

The purpose of this study is to evaluate the safety and efficacy of the long-acting injectable integrase inhibitor cabotegravir (CAB LA) compared to daily oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) for pre-exposure prophylaxis (PrEP) in a population of sexually active HIV-uninfected women at risk for HIV. This study will take place ...

Phase

0.35 miles

Learn More »

Efficacy Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses Early Dose 4 and Yearly Doses in Children 5-17 Months of Age

The current study intends to establish proof of concept (POC) for a fractional dose schedule under conditions of natural exposure. The study will be conducted in children 5-17 months old at first vaccination living in areas of mid to high malaria transmission, in line with the age group recommended by ...

Phase

0.35 miles

Learn More »